Combination Therapy Using Smac Peptide and Doxorubicin-encapsulated MUC 1-targeted Polymeric Nanoparticles to Sensitize Cancer Cells to Chemotherapy: An in vitro and in vivo Study
Publication date: Available online 15 July 2020Source: International Journal of PharmaceuticsAuthor(s): Mojgan Nejabat, Farhad Eisvand, Fatemeh Soltani, Mona Alibolandi, Seyed Mohammad Taghdisi, Khalil Abnous, Farzin Hadizadeh, Mohammad Ramezani
Source: International Journal of Pharmaceutics - Category: Drugs & Pharmacology Source Type: research
More News: Cancer | Cancer & Oncology | Chemotherapy | Drugs & Pharmacology | Nanotechnology | Study